Outcomes in Systemic Sclerosis Patients Treated with Rituximab and Mycophenolate Mofetil Combination Therapy Compared to Autologous Hematological Stem Cell Transplantation

被引：0
|
作者：
Keret, Shiri [1 ]
Kaly, Lisa [2 ]
Shouval, Aniela [2 ]
Zuckerman, Tsila [3 ]
Henig, Israel [4 ]
Awisat, Abid [5 ]
Rosner, Itzhak [6 ]
Rozenbaum, Michel [2 ]
Boulman, Nina [2 ]
Molad, Yair [7 ,8 ]
Lazar, Ariela Dortort [9 ,10 ]
Slobodin, Gleb [2 ]
Rimar, Doron [2 ]
机构：
[1] Bnai Zion, Atlit, Israel
[2] Bnai Zion Med Ctr, Haifa, Israel
[3] Rambam Med Ctr, Dept Hematol, Haifa, Israel
[4] Rambam Med Ctr, Dept Hematol, Stem Cell Transplantat Unit, Haifa, Israel
[5] Bney Zion Med Ctr, Baqa Elgharbiya, Israel
[6] Technion, Bnai Zion Med Ctr, Haifa, Israel
[7] Beilinson Med Ctr, Rabin Med Ctr, Petah Tiqwa, Israel
[8] Tel Aviv Univ, Petah Tiqwa, Israel
[9] Rabin Med Ctr, Tel Aviv, Israel
[10] Tel Aviv Univ, Tel Aviv, Israel
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1702
引用
收藏
页码：3396 / 3398
页数：3
相关论文
共 50 条
  • [1] OUTCOMES IN SYSTEMIC SCLEROSIS PATIENTS TREATED WITH RITUXIMAB AND MYCOPHENOLATE MOFETIL COMBINATION THERAPY COMPARED TO HEMATOLOGICAL STEM CELL TRANSPLANTATION
    Keret, S.
    Kaly, L.
    Shouval, A.
    Zuckerman, T.
    Henig, I.
    Awisat, A.
    Rosner, I.
    Boulman, N.
    Rozenbaum, M.
    Lazar, A. Dortort
    Slobodin, G.
    Rimar, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1009 - 1010
  • [2] Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapy
    Keret, Shiri
    Henig, Israel
    Zuckerman, Tsila
    Kaly, Lisa
    Shouval, Aniela
    Awisat, Abid
    Rosner, Itzhak
    Rozenbaum, Michael
    Boulman, Nina
    Lazar, Ariela Dortort
    Molad, Yair
    Sabbah, Firas
    Naffaa, Mohammad E.
    Hardak, Emilia
    Slobodin, Gleb
    Rimar, Doron
    RHEUMATOLOGY, 2024, 63 (06) : 1534 - 1538
  • [3] Upfront Combination Therapy With Rituximab and Mycophenolate Mofetil for Progressive Systemic Sclerosis
    Rimar, Doron
    Rosner, Itzhak
    Slobodin, Gleb
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (02) : 304 - +
  • [4] Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional Therapy
    Gregory, Kate
    Hansen, Dylan
    Penglase, Ross
    Apostolopoulos, Diane
    Ngian, Gene-Siew
    Stevens, Wendy
    Morrisroe, Kathleen
    Ferdowsi, Nava
    Ross, Laura
    Walker, Jennifer
    Cooley, Helen
    Youssef, Peter
    Tymms, Kathleen
    Host, Lauren
    Proudman, Susanna
    Moore, John
    Nikpour, Mandana
    Sahhar, Joanne
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (08) : 1294 - 1302
  • [5] PRELIMINARY ANALYSIS OF A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS TREATED WITH RITUXIMAB AND MYCOPHENOLATE MOFETIL
    Fraticelli, P.
    Fischetti, C.
    Manfredi, L.
    Albani, L.
    Mattioli, M.
    Gabrielli, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 604 - 604
  • [6] Autologous Hematological Stem Cell Transplantation for Systemic Sclerosis in Israel
    Rimar, Doron
    Aviel, Yonatan Butbul
    Gefen, Aharon
    Nevo, Neta
    Shen-Orr, Shai S.
    Starosvetsky, Elina
    Rosner, Itzhak
    Rozenbaum, Michael
    Kaly, Lisa
    Boulman, Nina
    Slobodin, Gleb
    Zuckerman, Tsila
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2020, 22 (02): : 104 - 110
  • [7] Outcomes of conventionally-treated systemic sclerosis patients eligible for autologous haematopoietic stem cell transplantation
    Panopoulos, S. T.
    Tektonidou, M. G.
    Bournia, V-K
    Laskari, K.
    Sfikakis, P. P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (04) : S29 - S33
  • [8] COMBINATION THERAPY WITH RITUXIMAB AND MYCOPHENOLATE MOFETIL IN SYSTEMIC SCLEROSIS. SAFETY AND EFFICACY FROM 12 MONTHS
    Fraticelli, P.
    Fischetti, C.
    Salaffi, F.
    Carotti, M.
    Pomponio, G.
    Gabrielli, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 526 - 526
  • [9] Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab
    Gernert, Michael
    Tony, Hans-Peter
    Froehlich, Matthias
    Schwaneck, Eva Christina
    Schmalzing, Marc
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [10] Combination therapy with rituximab and mycophenolate mofetil in systemic sclerosis. A single-centre case series study
    Fraticelli, P.
    Fischetti, C.
    Salaffi, F.
    Carotti, M.
    Mattioli, M.
    Pomponio, G.
    Gabrielli, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : S142 - S145
12345